Save Sight Institute

Save Sight Institute The Save Sight Institute leads the way in finding innovative new ways to preserve and restore vision

The Institute is active in three broad areas - research, teaching and clinical services.

Congratulations to PhD student Amber Zhang from the Macula Research Group, for receiving a travel grant from the Centre ...
07/07/2025

Congratulations to PhD student Amber Zhang from the Macula Research Group, for receiving a travel grant from the Centre for Drug Discovery Innovation to present her research at the recently concluded Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Salt Lake City!

Amber’s work focuses on understanding RNA expression in the macular and mid-peripheral retina. Her research lays the groundwork for the development of new therapies for retinal diseases. We're proud of you, Amber! 🎉

One month to go til  !Register now for the annual DryEyeClub: Seeing Outcomes webinar on 23 July, 5-6 PM AEST to hear fr...
23/06/2025

One month to go til !

Register now for the annual DryEyeClub: Seeing Outcomes webinar on 23 July, 5-6 PM AEST to hear from leading dry eye research experts and clinicians on:

💡 What is real world data and why is it useful? (Save Sight Dry Eye Registry)
💡 Understanding dry eye disease symptoms in everyday practice
💡 Real world outcomes of dry eye symptoms and clinical signs from everyday clinical practice
💡 Simple solutions to enhance everyday eye comfort and health in dry eye disease
💡 Patient lived experience with dry eye disease

The webinar will be hosted by Professor Stephanie Watson OAM, FARVO Head of the Corneal Research Group, and Chief Investigator of Save Sight Dry Eye Registry, and moderated by Dr Maria Cabrera from Sydney Medical School, The University of Sydney.

Register through the link in the comments. See you there!
---

Why is it that eye diseases like macular degeneration and diabetic retinopathy affect our central vision while others, l...
18/06/2025

Why is it that eye diseases like macular degeneration and diabetic retinopathy affect our central vision while others, like retinitis pigmentosa, start at the edges? 🤔

A new publication from the Save Sight Institute’s Macula Research Group offers clues: it turns out that the centre of our retina (the macula) may not be as well equipped to handle stress from light and oxidative damage.

The group found that in the outer retina, cells known as Müller glia activate genes that protect themselves from stress. But in the macula, these same cells activate genes that focus more on maintaining visual function—explaining why the macula may be more vulnerable to degenerative eye diseases associated with oxidative damage.

Notably, this study is the first to characterise Müller glia populations.

Read the article in the comments below! 👇

The Save Sight Institute invites you to join Eye Empower, a Virtual Peer Group for 12 – 25 year old youth and young adul...
16/06/2025

The Save Sight Institute invites you to join Eye Empower, a Virtual Peer Group for 12 – 25 year old youth and young adults who live with or experience the impacts of vision-related conditions and/or impairments.

This group is led by Salonee Goyal-Devaraj and Simran Goyal, two young professionals who are passionate about ensuring people who live with differing abilities have access to equal opportunities as their able-sighted peers.

In this session, a panel of youth and young adults with vision-related conditions and/or impairments will share their personal experiences navigating key life transitions, including those related to education and career.

Please join us, as they speak to what it means to lead without limits.

Session details:
Date: 8 August 2025 (Friday)
Time: 5:00pm to 6:30pm
Location: Online – Teams

Sign up through the link below!
---

Hot off the press 🔥Researchers from the Save Sight Institute's Corneal Research Group have just published a systematic r...
06/06/2025

Hot off the press 🔥

Researchers from the Save Sight Institute's Corneal Research Group have just published a systematic review in the British Journal of Ophthalmology. In their review, the authors explored how long it takes for the cornea to return to its natural shape after contact lens discontinuation.

They found that stabilisation time varied significantly based on lens type. For instance, it can take:

👁️ 2–11.6 weeks for soft lenses
👁️ 1–22 weeks for hard lenses
👁️ 1–2 weeks for orthokeratology lenses
👁️ Only a few hours for tinted lenses
..for the cornea to return to baseline after stopping use! Their findings help eye care professionals advise on how long patients should stop contact lens wear for accurate testing and pre-surgical planning.

Read the full article in the comments below! 👇
----

🚨Webinar alert🚨Join us for the annual DryEyeClub: Seeing Outcomes webinar on 23 July, 5-6 PM AEST to hear from leading d...
28/05/2025

🚨Webinar alert🚨

Join us for the annual DryEyeClub: Seeing Outcomes webinar on 23 July, 5-6 PM AEST to hear from leading dry eye research experts and clinicians on:

💡 What is real world data and why is it useful? (Save Sight Dry Eye Registry)
💡 Understanding dry eye disease symptoms in everyday practice
💡 Real world outcomes of dry eye symptoms and clinical signs from everyday clinical practice
💡 Simple solutions to enhance everyday eye comfort and health in dry eye disease
💡 Patient lived experience with dry eye disease

The webinar will be hosted by Professor Stephanie Watson OAM, FARVO Head of the Corneal Research Group, and Chief Investigator of Save Sight Dry Eye Registry, and moderated by Dr Maria Cabrera from Sydney Medical School, The University of Sydney.

Registration is now open through the link in the comments. See you there!

To round off Macula Month, the Save Sight Institute hosted our annual Macular Milestones Community Research Update last ...
26/05/2025

To round off Macula Month, the Save Sight Institute hosted our annual Macular Milestones Community Research Update last 19th May 2025. The event is a chance for the community to hear directly from leading researchers about the latest in macular disease research and treatments.

This year’s speakers included:
💡Professor Mark Gillies, who shared insights on geographic atrophy: what it is, why it matters, and what treatments are in development
💡Professor Matthew Simunovic, who presented results from the 1-step versus 2-step subretinal injection trial (1,2 SIT)
💡Associate Professor Ling Zhu, who showcased the Macula Research Group’s innovative macula-on-a-chip system that uses donated human maculas to study diseases in a laboratory setting

The event was a fantastic opportunity for learning, connection, and collaboration—with strong attendance from patients, orthoptists, students, and curious community members.

We’re grateful to all who joined us and look forward to welcoming even more members of the community next year. Stay tuned!

Missed Macular Milestones? Check out the event recording in the comments below 👇

---

 : Do you have an inherited retinal disease, age-related macular degeneration or are a caregiver of someone with either ...
21/05/2025

: Do you have an inherited retinal disease, age-related macular degeneration or are a caregiver of someone with either of these conditions?

Participate in a short online survey to share your thoughts on the future of cell therapies through the link below!

Eye Empower is fast approaching!Eye Empower is SSI’s Peer Group for 12-25 year old youth and young adults who live with ...
15/04/2025

Eye Empower is fast approaching!

Eye Empower is SSI’s Peer Group for 12-25 year old youth and young adults who live with or experience the impacts of vision-related conditions and/or impairments 👁️💪

The session will be led by Simran Goyal and Salonee Goyal-Devaraj, two young professionals who are passionate about ensuring people who live with differing abilities have access to equal opportunities as their able sighted peers.

In this session, registered psychologist Dr. Chrissy Antonopoulos will be presenting on the topic of Rights & Disclosure in Education, Work, and Relationships 🤝

Session details:
Date: 9 May 2025 (Friday)
Time: 5:00pm to 6:30pm
Location: Online – Microsoft Teams

Sign up through the link below 👇

Macular Milestones is back! 🎉Join on 19 May 2025 (Monday), 11am to 1pm to learn about the latest developments in treatin...
14/04/2025

Macular Milestones is back! 🎉

Join on 19 May 2025 (Monday), 11am to 1pm to learn about the latest developments in treating macular disease and preventing blindness from leading experts.

Agenda:
💡Associate Professor Ling Zhu: Macula-on-a-Chip: Laboratory research on donated human maculas in a dish
💡Professor Mark Gillies: Complement inhibitors, the 1st treatment for atrophic (advanced dry) macular degeneration
💡Professor Matthew Simunovic: Full results of 1,2-SIT - a trial comparing 2 different approaches to injecting therapeutics under the retina

This event is free and will be held in-person. Light refreshments will be served from 12pm to 1pm.

Click the link below to register. See you there!

Save the date 🗓️ Hear from Save Sight Institute's leading macular researchers on 19 May 2025 (Monday) as they share rece...
30/03/2025

Save the date 🗓️

Hear from Save Sight Institute's leading macular researchers on 19 May 2025 (Monday) as they share recent updates on treatments and therapies!

Here’s what you can expect:
🎤 Associate Professor Ling Zhu: Macula-on-a-Chip: Laboratory research on donated human maculas in a dish
🎤 Professor Mark Gillies: Complement inhibitors, the 1st treatment for atrophic (advanced dry) macular degeneration
🎤 Professor Matthew Simunovic: Full results of 1,2-SIT - a trial comparing 2 different approaches to injecting therapeutics under the retina

This event is free and will be held in-person. Talks will be held from 11am to 12pm, followed by light refreshments from 12pm to 1pm.

Register through the link in the comments! 👇
---

🚨New publication alert🚨In a systematic review and meta-analysis published in Clinical and Experimental Ophthalmology, th...
25/03/2025

🚨New publication alert🚨

In a systematic review and meta-analysis published in Clinical and Experimental Ophthalmology, the Save Sight Institute’s Corneal Research Group collaborated with other experts in the field to address the challenge of finding evidence on the use of topical ciclosporin for ocular surface disease 🧐

The review found that topical ciclosporin may be more effective in relieving symptoms on the cornea and conjunctiva in ocular surface disease compared to other frequently used topical therapeutics.

However, more robust, long-term clinical trials are needed to fully evaluate topical ciclosporin’s efficacy for dry eye treatment.

Read their review through the link in the comments!

---

Address

Woolloomooloo, NSW

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 4:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Alerts

Be the first to know and let us send you an email when Save Sight Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Save Sight Institute:

Share